Trends in utilization, mortality, and resource use after implantation of left ventricular assist devices in the United States

被引:8
|
作者
Sanaiha, Yas [1 ]
Downey, Peter [1 ,2 ]
Lyons, Robert [1 ,2 ]
Nsair, Ali [3 ]
Shemin, Richard J. [1 ,2 ]
Benharash, Peyman [1 ,2 ]
机构
[1] Univ Calif Los Angeles, Cardiovasc Outcomes Res Labs CORELAB, Los Angeles, CA USA
[2] Univ Calif Los Angeles, Div Cardiac Surg, Los Angeles, CA USA
[3] Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA USA
关键词
left ventricular assist device; volume-outcome; trends; resource utilization; mortality; DESTINATION THERAPY; HOSPITAL VOLUME; HEART-FAILURE; OUTCOMES; IMPACT; REGISTRY; SURGEON; COST; CARE;
D O I
10.1016/j.jtcvs.2019.12.121
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Adoption of implantable left ventricular assist devices has dramatically improved survival and quality of life in suitable patients with end-stage heart failure. In the era of value-based healthcare delivery, assessment of clinical outcomes and resource use associated with left ventricular assist devices is warranted. Methods: Adult patients undergoing left ventricular assist device implantation from 2008 to 2016 were identified using the National Inpatient Sample. Hospitals were designated as low-volume, medium-volume, or high-volume institutions based on annual institutional left ventricular assist device case volume. Multivariable logistic regression was used to evaluate adjusted odds of mortality across left ventricular assist device volume tertiles. Results: Over the study period, an estimated 23,972 patients underwent left ven-tricular assist device implantation with an approximately 3-fold increase in the num-ber of annual left ventricular assist device implantations performed (P for trend<.001). In-hospital mortality in patients with left ventricular assist devices decreased from 19.6% in 2008 to 8.1% in 2016 (P for trend<.001) and was higher at low-volume institutions compared with high-volume institutions (12.0% vs 9.2%, P < .001). Although the overall adjusted mortality was higher at low-volume compared with high-volume institutions (adjusted odds ratio, 1.66; 95% confidence interval, 1.28-2.15), this discrepancy was only significant for 2008 and 2009 (low-volume 2008 adjusted odds ratio, 5.5; 95% confidence interval, 1.9-15.8; low-volume 2009 adjusted odds ratio, 2.3; 95% confidence interval, 1.4-3.8). Conclusions: Left ventricular assist device use has rapidly increased in the United States with a concomitant reduction in mortality and morbidity. With maturation of left ventricular assist device technology and increasing experience, volume-related variation in mortality and resource use has diminished. Whether the apparent uni-formity in outcomes is related to patient selection or hospital quality deserves further investigation.
引用
收藏
页码:2083 / 2090
页数:8
相关论文
共 50 条
  • [41] Risk of Liver Dysfunction After Left Ventricular Assist Device Implantation
    Rosenbaum, Andrew N.
    Ternus, Bradley W.
    Pahwa, Siddharth
    Stulak, John M.
    Clavell, Alfredo L.
    Schettle, Sarah D.
    Behfar, Atta
    Jentzer, Jacob C.
    ANNALS OF THORACIC SURGERY, 2021, 111 (06) : 1961 - 1967
  • [42] Preoperative hyponatremia and survival after left ventricular assist device implantation
    Lamba, Harveen K.
    Parikh, Umang M.
    Vincent, Justin
    Civitello, Andrew B.
    Nair, Ajith
    Bhardwaj, Anju
    Senussi, Mourad H.
    Loor, Gabriel
    Shafii, Alexis E.
    Liao, Kenneth K.
    Chatterjee, Subhasis
    ARTIFICIAL ORGANS, 2022, 46 (09) : 1923 - 1931
  • [43] Long-term use of left ventricular assist devices: a report on clinical outcomes
    Raju, Sneha
    MacIver, Jane
    Foroutan, Farid
    Alba, Carolina
    Billia, Filio
    Rao, Vivek
    CANADIAN JOURNAL OF SURGERY, 2017, 60 (04) : 236 - 246
  • [44] Cardiac Transplantation After Bridged Therapy with Continuous Flow Left Ventricular Assist Devices
    Deo, Salil V.
    Sung, Kiick
    Daly, Richard C.
    Shah, Ishan K.
    Altarabsheh, Salah E.
    Stulak, John M.
    Joyce, Lyle D.
    Boilson, Barry A.
    Kushwaha, Sudhir S.
    Park, Soon J.
    HEART LUNG AND CIRCULATION, 2014, 23 (03) : 224 - 228
  • [45] Improvement in Blood Glucose Control in Patients With Diabetes After Implantation of Left Ventricular Assist Devices
    Guglin, Maya
    Maguire, Kim
    Missimer, Taylor
    Faber, Cristiano
    Caldeira, Christiano
    ASAIO JOURNAL, 2014, 60 (03) : 290 - 293
  • [46] Association between pulmonary artery pulsatility and mortality after implantation of left ventricular assist device
    Akamkam, Ali
    Galand, Vincent
    Jungling, Marie
    Delmas, Clement
    Dambrin, Camille
    Pernot, Mathieu
    Kindo, Michel
    Gaudard, Philippe
    Rouviere, Philippe
    Senage, Thomas
    Chavanon, Olivier
    Para, Marylou
    Gariboldi, Vlad
    Pozzi, Matteo
    Litzler, Pierre-Yves
    Babatasi, Gerard
    Bouchot, Olivier
    Radu, Costin
    Bourguignon, Thierry
    D'Ostrevy, Nicolas
    Akar, Ramzi Abi
    Vanhuyse, Fabrice
    Gaillard, Maira
    Chatelier, Gilles
    Fels, Audrey
    Flecher, Erwan
    Guihaire, Julien
    ESC HEART FAILURE, 2024, 11 (04): : 2100 - 2112
  • [47] Preoperative Pectoralis Muscle Quantity and Attenuation by Computed Tomography Are Novel and Powerful Predictors of Mortality After Left Ventricular Assist Device Implantation
    Teigen, Levi M.
    John, Ranjit
    Kuchnia, Adam J.
    Nagel, Emily M.
    Earthman, Carrie P.
    Kealhofer, Jessica
    Martin, Cindy
    Cogswell, Rebecca
    CIRCULATION-HEART FAILURE, 2017, 10 (09)
  • [48] Evolution of indications for cardiac transplantation and implantation of left ventricular assist devices
    Ammirati, Enrico
    Oliva, Fabrizio
    Colombo, Tiziano
    Botta, Luca
    Cipriani, Manlio
    Cannata, Aldo
    Verde, Alessandro
    Turazza, Fabio M.
    Russo, Claudio F.
    Paino, Roberto
    Martinelli, Luigi
    Frigerio, Maria
    GIORNALE ITALIANO DI CARDIOLOGIA, 2013, 14 (02) : 110 - 119
  • [49] Gender Differences in Utilization and Hospitalization Outcomes in Patients Undergoing Left Ventricular Assist Device Implantation in the United States.
    Ahmed, Abdelrahman
    Akintoye, Emmanuel
    Adegbala, Oluwole
    Ajam, Mustafa
    Yassin, Ahmed
    Abubakar, Hossam
    Subahi, Ahmed
    Aldiwani, Haider
    Ahmed, Marwa
    Shokr, Mohamed
    Afonso, Luis
    CIRCULATION, 2018, 138
  • [50] Readmissions after Acute Kidney Injury during Left Ventricular Assist Device Implantation Hospitalization
    Walther, Carl P.
    Winkelmayer, Wolfgang C.
    Deswal, Anita
    Niu, Jingbo
    Navaneethan, Sankar D.
    AMERICAN JOURNAL OF NEPHROLOGY, 2020, 51 (03) : 172 - 181